This company listing is no longer active
ProMIS Neurosciences Croissance future
Future contrôle des critères 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for ProMIS Neurosciences.
Informations clés
9.3%
Taux de croissance des bénéfices
13.3%
Taux de croissance du BPA
Biotechs croissance des bénéfices | 36.6% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 17 Jul 2023 |
Mises à jour récentes de la croissance future
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2025 | N/A | -18 | N/A | N/A | 1 |
12/31/2024 | N/A | -14 | N/A | N/A | 1 |
12/31/2023 | N/A | -17 | N/A | N/A | 1 |
3/31/2023 | N/A | -21 | -16 | -16 | N/A |
12/31/2022 | N/A | -18 | -17 | -17 | N/A |
9/30/2022 | 0 | -12 | -16 | -16 | N/A |
6/30/2022 | 0 | -8 | -15 | -15 | N/A |
3/31/2022 | N/A | -6 | -12 | -12 | N/A |
12/31/2021 | N/A | -10 | -9 | -9 | N/A |
9/30/2021 | N/A | -8 | -6 | -6 | N/A |
6/30/2021 | N/A | -8 | -4 | -4 | N/A |
3/31/2021 | 0 | -9 | -3 | -3 | N/A |
12/31/2020 | 0 | -4 | -4 | -3 | N/A |
9/30/2020 | 0 | -5 | -4 | -4 | N/A |
6/30/2020 | 0 | -5 | -4 | -4 | N/A |
3/31/2020 | 0 | -5 | -4 | -4 | N/A |
12/31/2019 | 0 | -6 | -5 | -5 | N/A |
9/30/2019 | 0 | -7 | -6 | -6 | N/A |
6/30/2019 | 0 | -8 | -7 | -7 | N/A |
3/31/2019 | 0 | -8 | -7 | -7 | N/A |
12/31/2018 | 0 | -7 | -6 | -6 | N/A |
9/30/2018 | 0 | -6 | -6 | -6 | N/A |
6/30/2018 | 0 | -5 | -5 | -5 | N/A |
3/31/2018 | 0 | -5 | -5 | -5 | N/A |
12/31/2017 | 0 | -5 | -5 | -5 | N/A |
9/30/2017 | 0 | -5 | -4 | -4 | N/A |
6/30/2017 | 0 | -4 | -3 | -3 | N/A |
3/31/2017 | 0 | -3 | -3 | -3 | N/A |
12/31/2016 | 0 | -3 | N/A | -2 | N/A |
9/30/2016 | 0 | -2 | N/A | -2 | N/A |
6/30/2016 | 0 | -2 | N/A | -2 | N/A |
3/31/2016 | 0 | -2 | N/A | -2 | N/A |
12/31/2015 | 0 | -2 | N/A | -1 | N/A |
9/30/2015 | 0 | -1 | N/A | -1 | N/A |
6/30/2015 | 0 | -2 | N/A | -1 | N/A |
3/31/2015 | 0 | -2 | N/A | -1 | N/A |
12/31/2014 | 0 | -2 | N/A | -2 | N/A |
9/30/2014 | 0 | -3 | N/A | -2 | N/A |
6/30/2014 | 0 | -2 | N/A | -2 | N/A |
3/31/2014 | 0 | -2 | N/A | -2 | N/A |
12/31/2013 | 0 | -2 | N/A | -1 | N/A |
9/30/2013 | 0 | -2 | N/A | -1 | N/A |
6/30/2013 | 0 | -2 | N/A | -2 | N/A |
3/31/2013 | 0 | -2 | N/A | -2 | N/A |
12/31/2012 | 0 | -2 | N/A | -2 | N/A |
9/30/2012 | 0 | -3 | N/A | -3 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: PMN is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: PMN is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: PMN is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if PMN's revenue is forecast to grow faster than the Canadian market.
Croissance élevée des revenus: PMN is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if PMN's Return on Equity is forecast to be high in 3 years time